ILMN Illumina Earnings and EPS analysis

Relative Growth: Rel. Growth: 32

Relative Strength: Rel. Strength: 70

Relative Valuation: Rel. Valuation: 66

Relative Profitability: Rel. Profitability: 97

EPS in 2025 (TTM): $4.47

Last Report Period Date: Sep 28, 2025

As of November 2025, according to Illumina's latest financial report, the company's current EPS (TTM) is $4.47. In 2024, the company recorded an earnings per share (EPS) of -$7.69, which represents a decrease compared to its EPS of -$7.34 in 2023. Illumina's earnings per share for the quarterly report ending on Sep 28, 2025 was $0.98.

ILMN earnings history

Historical annual and quarterly earnings per share (EPS) data for Illumina

EPS (TTM)

$4.47

EPS Growth YoY (Quarterly)

-77.9%

EPS (Quarterly)

$0.98

EPS Growth (Quarterly)

-34.2%

The annual EPS in 2024 was -$7.69, a decrease of 4.8% from -$7.34 in 2023. For the quarter ending Sep 28, 2025, the EPS was $0.98, showing a 77.9% decrease from the same quarter last year. The trailing twelve months (TTM) EPS as of September 2025 is $4.47. In 2023, the annual EPS was -$7.34, showing an increase of 73.8% from 2022.

ILMN EPS growth

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

-77.9%

EPS growth YoY

-4.8%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Over the last 12 months, Illumina has registered an EPS growth of -77.9% (YoY, quarterly).

ILMN Earnings Waterfall

Breakdown of revenue, profit and net income for Illumina

ILMN Earnings vs Peers

What are the earnings of ILMN compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
DGX Quest Diagnostics Inc	20.63	2.5%	-21.1%	4.1%
ILMN Illumina Inc	27.39	-4.8%	N/A	N/A
TMO Thermo Fisher Scientific Inc	32.74	6.8%	-5.5%	12.4%
A Agilent Technologies Inc	34.29	5.2%	3.7%	5.4%
DHR Danaher Corp	43.49	-17.2%	-15.3%	5.3%
PACB Pacific Biosciences Of California Inc	N/A	6.6%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.